← All cap tiers
Cap tier

Small Cap

Every analyzed stock in Small Cap — 1,523 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
Sort by: A–Z Most overvalued Most shorted Buyers' strike Largest
XPEL
XPEL, Inc.
Fairly valued
Industrials
Price$44.43
Model IV$45.91
P/IV1.00
Discount 3% Return to IV: +3.3%
Market implies +9.0%/yr vs model +13.3% · below model
XPRO
Expro Ltd
Valuation N/A
Energy
Price$16.17
Model IV—
P/IV—
Limited data — see page
XRN
Chiron Real Estate Inc.
Valuation N/A
Financial Services
Price$33.59
Model IV—
P/IV—
Limited data — see page
XRX
Xerox Holdings Corp
Valuation N/A
Technology
Price$2.75
Model IV—
P/IV—
Market implies -19.3%/yr vs model +7.6% · below model
XYF
X Financial
Deeply undervalued
Financial Services
Price$5.15
Model IV$14.32
P/IV0.37
Discount 64% Return to IV: +178.1%
Market implies -7.0%/yr vs model +10.9% · below model
XZO
Exzeo Group, Inc.
Deeply undervalued
Technology
Price$15.98
Model IV$40.04
P/IV0.38
Discount 60% Return to IV: +150.5%
Market implies +5.0%/yr vs model +25.0% · below model
YALA
Yalla Group Ltd
Deeply undervalued
Technology
Price$5.51
Model IV$11.52
P/IV0.19
Discount 52% Return to IV: +109.1%
Market implies -4.9%/yr vs model +7.6% · below model
YELP
YELP INC
Deeply undervalued
Consumer Cyclical
Price$18.59
Model IV$57.03
P/IV0.31
Discount 67% Return to IV: +206.8%
Market implies -9.6%/yr vs model +8.4% · below model
YEXT
Yext, Inc.
Fairly valued
Technology
Price$6.93
Model IV$6.82
P/IV0.61
Premium +2% Return to IV: -1.6%
Market implies -2.9%/yr vs model +3.4% · below model
YI
111, Inc.
Deeply overvalued
Consumer Cyclical
Price$3.15
Model IV$1.57
P/IV3.36
Premium +100% Return to IV: -50.1%
Market implies +10.5%/yr vs model +3.0% · above model
YMT
Yimutian Inc.
Valuation N/A
Technology
Price$0.99
Model IV—
P/IV—
Market implies +41.4%/yr vs model +15.0% · above model
YORW
YORK WATER CO
Deeply overvalued
Utilities
Price$31.06
Model IV$15.65
P/IV1.98
Premium +98% Return to IV: -49.6%
YQ
17 Education & Technology Group Inc.
Valuation N/A
Consumer Defensive
Price$3.39
Model IV—
P/IV—
Market implies +60.4%/yr vs model +2.0% · above model
YSS
York Space Systems Inc.
Valuation N/A
Consumer Cyclical
Price$7.11
Model IV—
P/IV—
Limited data — see page
YYAI
AIRWA INC.
Valuation N/A
Technology
Price$0.71
Model IV—
P/IV—
Market implies -5.1%/yr vs model +15.0% · below model
ZBIO
Zenas BioPharma, Inc.
Valuation N/A
Healthcare
Price$27.26
Model IV—
P/IV—
Market implies +89.7%/yr vs model +2.0% · above model
ZD
ZIFF DAVIS, INC.
Deeply undervalued
Communication Services
Price$56.52
Model IV$99.97
P/IV0.15
Discount 43% Return to IV: +76.9%
Market implies -3.0%/yr vs model +6.7% · below model
ZG
ZILLOW GROUP, INC.
Deeply overvalued
Technology
Price$29.87
Model IV$15.46
P/IV0.17
Premium +93% Return to IV: -48.3%
Market implies +8.3%/yr vs model +4.9% · above model
ZH
Zhihu Inc.
Deeply overvalued
Technology
Price$3.47
Model IV$1.18
P/IV2.96
Premium +194% Return to IV: -66.0%
Market implies +16.2%/yr vs model +2.0% · above model
ZJYL
Jin Medical International Ltd.
Valuation N/A
Healthcare
Price$2.06
Model IV—
P/IV—
Market implies +54.3%/yr vs model +2.0% · above model
ZURA
Zura Bio Ltd
Valuation N/A
Healthcare
Price$4.00
Model IV—
P/IV—
Limited data — see page
ZVRA
ZEVRA THERAPEUTICS, INC.
Fairly valued
Healthcare
Price$11.39
Model IV$12.28
P/IV0.94
Discount 7% Return to IV: +7.8%
Market implies -6.0%/yr vs model +38.8% · below model
ZYME
Zymeworks Inc.
Deeply overvalued
Healthcare
Price$25.79
Model IV$6.47
P/IV4.25
Premium +298% Return to IV: -74.9%
Market implies +17.1%/yr vs model +41.2% · below model